Jubilant Ingrevia Ltd (JUBLINGREA)
₹725.55
Mkt cap
₹11,557 Cr
P/E ratio
36.30
P/B
3.70
Div yield
0.69%
ROE
9.51%
ROCE
11.40%
EPS (TTM)
₹19.99
Book value
₹196
52W range
541–831
Sector
Commodities
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards. Jubilant Ingrevia’s portfolio also extends to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis. [1]
Health check
Constructive
ValuationFair
ProfitabilityAverage
GrowthHigh
TechnicalsBullish
52-week range
−12.71% from high₹726
₹541+34.04% from low₹831
Current
₹725.55
Prev close
₹725.00
Day
+0.08%
Price performance
1D
+0.08%
1W
−1.53%
1M
+16.71%
3M
−1.76%
6M
+8.19%
1Y
−13.06%
YTD
−0.10%
Financials
FRevenue, profit & margin
P/E ratio
36.3×
JUBLINGREA is 14% above the sector median of 31.8×
JUBLINGREA36.3×
Sector median31.8×
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,075 | 1,020 | 966 | 1,074 | 1,024 | 1,045 | 1,057 | 1,051 | 1,038 | 1,121 | 1,051 | 1,179 | 1,300 | |
| Expenses | 958 | 902 | 871 | 983 | 915 | 921 | 918 | 905 | 896 | 985 | 924 | 1,016 | 1,101 | |
| Operating Profit | 117 | 118 | 96 | 91 | 110 | 124 | 138 | 147 | 142 | 135 | 126 | 163 | 199 | |
| OPM % | 11% | 12% | 10% | 8% | 11% | 12% | 13% | 14% | 14% | 12% | 12% | 14% | 15% | |
| Other Income | 8 | 9 | 9 | 10 | 10 | 10 | 9 | 8 | 11 | 11 | -4 | 9 | 10 | |
| Interest | 11 | 13 | 15 | 14 | 14 | 15 | 12 | 14 | 13 | 12 | 12 | 12 | 17 | |
| Depreciation | 32 | 34 | 34 | 36 | 39 | 40 | 40 | 39 | 41 | 41 | 45 | 48 | 51 | |
| Profit before tax | 81 | 80 | 55 | 51 | 66 | 80 | 96 | 102 | 100 | 93 | 65 | 112 | 141 | |
| Tax % | 29% | 28% | 30% | 43% | 26% | 26% | 27% | 27% | 25% | 25% | 28% | 23% | 25% | |
| Net Profit | 58 | 57 | 39 | 29 | 49 | 59 | 69 | 74 | 75 | 69 | 47 | 86 | 106 | |
| EPS in Rs | 3.62 | 3.61 | 2.42 | 1.84 | 3.06 | 3.70 | 4.36 | 4.65 | 4.71 | 4.36 | 2.94 | 5.43 | 6.64 | |
| Raw PDF |
Earnings
EResults dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
No reaction history yet.
No quarterly filings ingested yet.
Corporate actions
CLast 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
Sas of Jun 202645.22%Promoter
Promoters45.22%
FIIs6.49%
DIIs24.98%0.22
Public22.30%0.23
Government0.02%
Ownership trend
Peers
P8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Pidilite Inds. | ₹1,570.90 | 64.93 | 1,59,885 | 0.73% | 584 | +32.82% | 3,583 | +14.08% | 31.02% |
| Gujarat Fluoroch | ₹4,573.70 | 85.43 | 50,242 | 0.07% | 109 | −41.93% | 1,369 | +11.76% | 9.86% |
| Navin Fluo.Intl. | ₹7,520.00 | 59.53 | 38,583 | 0.20% | 213 | +113.03% | 938 | +33.78% | 20.96% |
| Deepak Nitrite | ₹1,649.60 | 40.81 | 22,499 | 0.45% | 220 | +8.56% | 2,120 | −2.72% | 11.37% |
| Aether Industri. | ₹1,427.50 | 83.74 | 18,945 | 0.00% | 54 | +4.78% | 305 | +27.03% | 11.92% |
| Atul | ₹6,407.50 | 23.72 | 18,865 | 0.47% | 254 | +91.99% | 1,848 | +25.03% | 14.90% |
| Aarti Industries | ₹477.80 | 42.07 | 17,331 | 0.21% | 137 | +42.71% | 2,205 | +13.13% | 6.85% |
| Jubilant Ingrev. | ₹725.55 | 36.34 | 11,557 | 0.69% | 106 | +40.91% | 1,300 | +25.28% | 11.35% |
| Median: 92 Co. | ₹290.23 | 31.78 | 987 | 0.29% | 12 | +32.82% | 167 | +13.23% | 13.89% |
Filings
DAnnual reports5
Concall transcripts55
PPTJul 2026RECJul 2026TranscriptMay 2026PPTMay 2026TranscriptFeb 2026PPTFeb 2026TranscriptOct 2025PPTOct 2025RECOct 2025TranscriptAug 2025PPTAug 2025TranscriptMay 2025PPTMay 2025RECMay 2025TranscriptMar 2025PPTMar 2025TranscriptJan 2025PPTJan 2025RECJan 2025TranscriptOct 2024TranscriptOct 2024PPTOct 2024TranscriptJul 2024PPTJul 2024
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Newspaper Publication 14h - Submission of unaudited Standalone and consolidated financial results for quarter ending June 30, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 1d - Audio recording of Q1 FY27 investors’ conference call uploaded on July 23, 2026.Announcement under Regulation 30 (LODR)-Investor Presentation 2d - Press Release and Investor Presentation on the Financials and Operational Performance of the Company for the quarter ended June 30, 2026Announcement under Regulation 30 (LODR)-Press Release / Media Release 2d - Jubilant Ingrevia posted Q1 FY27 revenue of ₹1,300 crore, EBITDA ₹209 crore, PAT ₹106 crore.Board Meeting Outcome for Outcome Of The Board Meeting Held On July 22, 2026 2d - Board approved unaudited Q1 FY27 standalone and consolidated results on July 22, 2026.